Status:
COMPLETED
A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 1
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This trial will compare the metabolic control in type 1 diabetes obtained by continuous infusion of insulin lispro with that obtained by multiple daily injections of insulin lispro and glargine, a lon...
Eligibility Criteria
Inclusion
- Type 1 diabetic patients, 18-60 years of age
- Diabetic for \>2 years
- Treated with CSII for \>=6 months
- HbA1c \<8.5%
Exclusion
- Treatment with daily insulin injections
- Inability to handle pump therapy
- Untreated retinopathy
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00468754
Start Date
July 1 2003
End Date
May 1 2005
Last Update
March 3 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Bergamo, Italy, 24128
2
Brescia, Italy, 25123
3
Padua, Italy, 35128
4
Pisa, Italy, 56124